SCHEMBL3184225

SCHEMBL3184225

CCCCCCCCCCCC(=O)c1ncc(-c2ccccn2)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.87
CES1 P23141 4/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3193003 1.00 FAAH (0.87) FAAHCES1
SCHEMBL3203324 1.00 FAAH (0.87) FAAHCES1
SCHEMBL3184664 1.00 FAAH (0.87) FAAHCES1
SCHEMBL3193497 1.00 FAAH (0.87) FAAHCES1
SCHEMBL3191682 1.00 FAAH (0.87) FAAHCES1
SCHEMBL3197441 1.00 FAAH (0.87) FAAHCES1
SCHEMBL3197318 1.00 FAAH (0.87) FAAHCES1
SCHEMBL3195864 0.99 FAAH (0.85) FAAHCES1
SCHEMBL3194478 0.95 FAAH (0.79) FAAHCES1
SCHEMBL719614 0.93 FAAH (0.83) FAAHCES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662971-B2 enzyme inhibitor for treating sleep disorders THE SCRIPPS RESEARCH INSTITUTE (US) 2010-02-16 US disclosed
EP-2093220-A2 Inhibitors of fatty acid amide hydrolase The Scripps Research Institute (US) 2009-08-26 EP disclosed
EP-1549624-B1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE SCRIPPS RESEARCH INST (US) 2009-05-13 EP disclosed
EP-1549624-A4 INHIBITORS OF FATTY ACID AMIDE HYDROLASE SCRIPPS RESEARCH INST (US) 2006-09-20 EP disclosed
US-20060111359-A1 enzyme inhibitor for treating sleep disorders THE SCRIPPS RESEARCH INSTITUTE (US) 2006-05-25 US disclosed
EP-1549624-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE The Scripps Research Institute (US) 2005-07-06 EP disclosed
WO-2004033652-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2004-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111359-A1 enzyme inhibitor for treating sleep disorders FAAH, FAAH2, HCRTR2 FAAH 1/4885CES1 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.